Add like
Add dislike
Add to saved papers

Health benefit assessment of PM 2.5 reduction in Pearl River Delta region of China using a model-monitor data fusion approach.

The Pearl River Delta (PRD), one of the most polluted and populous regions of China, experienced a 28% reduction in fine particulate matter (PM2.5 ) concentration between 2013 (47 μg/m3 ) and 2015 (34 μg/m3 ) under a stringent national policy known as the Air Pollution Prevention and Control Action Plan (hereafter Action Plan). In this study, the health and economic benefits associated with PM2.5 reductions in PRD during 2013-2015 were estimated using the Environmental Benefits Mapping and Analysis Program-Community Edition (BenMAP-CE) software. To create reliable gridded PM2.5 surfaces for BenMAP-CE calculations, a data fusion tool which incorporates the accuracy of monitoring data and the spatial coverage of predictions from the Community Multiscale Air Quality (CMAQ) model has been developed. The population-weighted average PM2.5 concentration over PRD was predicted to decline by 24%. PM2.5 -related mortality was estimated to decrease by more than 3800 due to decreases in stroke (48%), ischemic heart disease (IHD) (35%), chronic obstructive pulmonary disease (COPD) (10%), and lung cancer (LC) (7%). A 13% reduction in PM2.5 -related premature deaths from these four causes yielded a large economic benefit of about 1300 million US dollars. Our research suggests that the Action Plan played a major role in reducing emissions and additional measures should be implemented to further reduce PM2.5 pollution and protect public health in the future.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app